Universität zu Lübeck | Germany
Prof. Dr. med. Diamant Thaçi is a leading dermatologist and inflammation medicine expert whose career spans clinical practice, translational research, and academic leadership. After completing a postdoctoral fellowship and receiving a DAAD Scholarship for highly talented young scientists, he specialized in dermatology and venereology and advanced through key roles at J.W. Goethe University Frankfurt, including Senior Physician for dermatological clinical research and chronic inflammatory skin diseases. He later earned his venia legendi and held a W2 Professorship before assuming major leadership positions at the University of Lübeck, where he currently directs the Institute for Inflammation Medicine, the Excellence Center for Inflammation Medicine, and the Inflammation Board. His research focuses on atopic dermatitis, psoriasis, psoriatic arthritis, and novel immunomodulatory therapies, contributing extensively to pivotal international clinical trials. With 379 documents, 20,448 citations by 13,334 documents, and an h-index of 68, he is recognized as a Highly Cited Researcher and serves on multiple international councils and editorial boards. His awards include the Theodor Stern Foundation Prize and multiple distinctions from EADV and other societies. Overall, he is regarded as one of the most influential figures in modern inflammation and dermatology research.
Featured Publications
Curman, P., Thaçi, D., & Ludwig, R. J. (2025). “Increased Cardiovascular Risk in Chronic Spontaneous Urticaria: A Large Real-World Cohort Study” in Allergy.
Lebwohl, M., Gooderham, M. J., Warren, R. B., Thaçi, D., Foley, P., Gottlieb, A. B., Torres, T., Popmihajlov, Z., Jou, Y.-M., Linaberry, M., et al. (2025). “Outcomes of Psoriasis Area and Severity Index (PASI) and PASI components in two phase III trials of deucravacitinib in patients with moderate to severe plaque psoriasis” in Clinical and Experimental Dermatology.
Olbrich, H., Kridin, K., Zirpel, H., Hernandez, G., Sadik, C. D., Gaffal, E., Thaçi, D., & Ludwig, R. J. (2025). “Glucagon-like peptide-1 receptor agonists and reduced mortality, cardiovascular and psychiatric risks in patients with psoriasis: a large-scale cohort study” in British Journal of Dermatology.
Alfarsi, S., Recke, A., Gaffal, E., Klein, J. P., Zirpel, H., Kridin, K., Thaçi, D., Olbrich, H., Bieber, K., & Ludwig, R. J. (2025). “Increased risk of psychiatric disease in patients with prurigo nodularis” in British Journal of Dermatology.
Thaçi, D., Ohtsuki, M., Maul, J.-T., Szegedi, A., Luna, P. C., Lynde, C. W., Soliman, A. M., Wang, H., Kaufmann, C., Ashley, D. G., et al. (2025). “Correction: Real-World Effectiveness of Risankizumab in Patients with Moderate-to-Severe Psoriasis: Interim Analysis from the VALUE Global Prospective Post-marketing Observational Study at 25 Months” in Dermatology and Therapy.